{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:55:04Z","timestamp":1791842104975,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13063-016-1253-0","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T02:37:10Z","timestamp":1458614230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cognitive rehabiliation for Parkinson's disease dementia: a study protocol for a pilot randomised controlled trial"],"prefix":"10.1186","volume":"17","author":[{"given":"John V","family":"Hindle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamlyn J","family":"Watermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Martyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw","family":"Lloyd-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Gutting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Hoare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon Tudor","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Clare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"key":"1253_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5:235\u201345.","journal-title":"Lancet Neurol."},{"key":"1253_CR2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","volume":"9","author":"AA Kehagia","year":"2010","unstructured":"Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease. Lancet Neurol. 2010;9:1200\u201313.","journal-title":"Lancet Neurol."},{"key":"1253_CR3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/jnnp.2007.134163","volume":"7","author":"I McKeith","year":"2007","unstructured":"McKeith I. Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide. Pract Neurol England. 2007;7:374\u201382.","journal-title":"Pract Neurol England."},{"key":"1253_CR4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med England. 2014;44:673\u201383.","journal-title":"Psychol Med England."},{"key":"1253_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.20726","volume":"21","author":"CC Janvin","year":"2006","unstructured":"Janvin CC, Larsen JP, Salmon DP, Galasko D, Hugdahl K, Aarsland D. Cognitive profiles of individual patients with Parkinson\u2019s disease and dementia: comparison with dementia with Lewy bodies and Alzheimer\u2019s disease. Mov Disord. 2006;21:337\u201342.","journal-title":"Mov Disord."},{"key":"1253_CR6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afp223","volume":"39","author":"JV Hindle","year":"2010","unstructured":"Hindle JV. Ageing, neurodegeneration and Parkinson\u2019s disease. Age Ageing. 2010;39:156\u201361.","journal-title":"Age Ageing."},{"key":"1253_CR7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/WAD.0b013e318065c4a9","volume":"21","author":"F Bostrom","year":"2007","unstructured":"Bostrom F, Jonsson L, Minthon L, Londos E. Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2007;21:150\u20134.","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"1253_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000316119","volume":"30","author":"J Olazaran","year":"2010","unstructured":"Olazaran J, Reisberg B, Clare L, Cruz I, Pena-Casanova J, Del Ser T, et al. Nonpharmacological therapies in Alzheimer\u2019s disease: a systematic review of efficacy. Dement Geriatr Cogn Disord. 2010;30:161\u201378.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"1253_CR9","doi-asserted-by":"crossref","unstructured":"Bahar-Fuchs A, Clare L, Woods B. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer\u2019s disease and vascular dementia. Cochrane Database Syst Rev. 2013. doi: 10.1002\/14651858.CD003260.pub2 .","DOI":"10.1002\/14651858.CD003260.pub2"},{"key":"1253_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/1360786021000045854","volume":"7","author":"L Clare","year":"2003","unstructured":"Clare L, Wilson BA, Carter G, Hodges JR. Cognitive rehabilitation as a component of early intervention in Alzheimer\u2019s disease: a single case study. Aging Ment Health England. 2003;7:15\u201321.","journal-title":"Aging Ment Health England."},{"key":"1253_CR11","doi-asserted-by":"crossref","unstructured":"Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev. 2011. doi: 10.1002\/14651858.CD006220.pub2 .","DOI":"10.1002\/14651858.CD006220.pub2"},{"key":"1253_CR12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/JGP.0b013e3181d5792a","volume":"18","author":"L Clare","year":"2010","unstructured":"Clare L, Linden DE, Woods RT, Whitaker R, Evans SJ, Parkinson CH, et al. Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy. Am J Geriatr Psychiatry. 2010;18:928\u201339.","journal-title":"Am J Geriatr Psychiatry."},{"key":"1253_CR13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1745-6215-14-152","volume":"14","author":"L Clare","year":"2013","unstructured":"Clare L, Bayer A, Burns A, Corbett A, Jones R, Knapp M, et al. Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT). Trials. 2013;14:152.","journal-title":"Trials."},{"key":"1253_CR14","doi-asserted-by":"crossref","unstructured":"Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease. Cochrane Database Syst Rev. 2012. doi: 10.1002\/14651858.CD006504.pub2 .","DOI":"10.1002\/14651858.CD006504.pub2"},{"key":"1253_CR15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/mds.25377","volume":"28","author":"JV Hindle","year":"2013","unstructured":"Hindle JV, Petrelli A, Clare L, Kalbe E. Nonpharmacological enhancement of cognitive function in Parkinson\u2019s disease: a systematic review. Mov Disord. 2013;28:1034\u201349.","journal-title":"Mov Disord."},{"key":"1253_CR16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2165\/11587110-000000000-00000","volume":"29","author":"J Dams","year":"2011","unstructured":"Dams J, Bornschein B, Reese J, Conrads-Frank A, Oertel W, Siebert U, et al. Modelling the cost effectiveness of treatments for Parkinson\u2019s disease. Pharmaeconomics. 2011;29:1025\u201349.","journal-title":"Pharmaeconomics."},{"key":"1253_CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000165917","volume":"26","author":"D Aarsland","year":"2008","unstructured":"Aarsland D, Rongve A, Nore SP, Skogseth R, Skulstad S, Ehrt U, et al. Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement Geriatr Cogn Disord. 2008;26:445\u201352.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"1253_CR18","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/sim.4175","volume":"30","author":"D Russell","year":"2011","unstructured":"Russell D, Hoare ZSJ, Whitaker R, Whitaker CJ, Russell IT. Generalized method for adaptive randomization in clinical trials. Stat Med. 2011;30:922\u201334.","journal-title":"Stat Med."},{"key":"1253_CR19","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","volume":"42","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson\u2019s disease: a clinicopathologic study. Neurology. 1992;42:1142\u20136.","journal-title":"Neurology."},{"key":"1253_CR20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord. 2007;22:1689\u2013707.","journal-title":"Mov Disord."},{"key":"1253_CR21","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, et al. Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007;22:2314\u201324.","journal-title":"Mov Disord."},{"key":"1253_CR22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863\u201372.","journal-title":"Neurology."},{"key":"1253_CR23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000351671","volume":"36","author":"S Hsieh","year":"2013","unstructured":"Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke\u2019s Cognitive Examination III in frontotemporal dementia and Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2013;36:242\u201350.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"1253_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1745-6215-13-115","volume":"13","author":"L Clare","year":"2012","unstructured":"Clare L, Hindle JV, Jones IR, Thom JM, Nelis SM, Hounsome B, et al. The AgeWell study of behavior change to promote health and wellbeing in later life: study protocol for a randomized controlled trial. Trials. 2012;13:115.","journal-title":"Trials."},{"key":"1253_CR25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archgenpsychiatry.2010.88","volume":"67","author":"SC Lidstone","year":"2010","unstructured":"Lidstone SC, Schulzer M, Dinelle K, Mak E, Sossi V, Ruth TJ, et al. Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry. 2010;67:857\u201365.","journal-title":"Arch Gen Psychiatry."},{"key":"1253_CR26","volume-title":"Delis-Kaplan Executive Function System (DKEFS)","author":"D Delis","year":"2001","unstructured":"Delis D, Kaplan E, Kramer J. Delis-Kaplan Executive Function System (DKEFS). London: Pearson; 2001."},{"key":"1253_CR27","volume-title":"The Test of Everyday Attention","author":"I Robertson","year":"1994","unstructured":"Robertson I, Ward T, Ridgeway V, Nimmo-Smith I. The Test of Everyday Attention. Thames Valley Test Company: St Edmunds; 1994."},{"key":"1253_CR28","volume-title":"Rivermead Behavioural Memory Test II","author":"B Wilson","year":"2003","unstructured":"Wilson B, Baddeley A, Cockburn J. Rivermead Behavioural Memory Test II. Thames Valley Test Company: St Edmonds; 2003."},{"key":"1253_CR29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.21333","volume":"22","author":"A Schrag","year":"2007","unstructured":"Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, et al. Depression rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord. 2007;22:1077\u201392.","journal-title":"Mov Disord."},{"key":"1253_CR30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"1253_CR31","first-page":"153","volume-title":"Recent developments in Parkinson\u2019s disease, Vol 2","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton R, Members of the Unified Parkinson\u2019s Disease Rating Scale (UPDRS) Development Committee. Unified Parkinson\u2019s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson\u2019s disease, Vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987. p. 153\u201363. p. 293\u2013304."},{"key":"1253_CR32","volume-title":"The Parkinson\u2019s Disease Questionnaire. User manual for the PDQ-39, PDQ-8 and the PDQ summary index","author":"C Jenkinson","year":"1998","unstructured":"Jenkinson C, Fitzpatrick R, Peto V. The Parkinson\u2019s Disease Questionnaire. User manual for the PDQ-39, PDQ-8 and the PDQ summary index. Oxford: Universtiy of Oxford; 1998."},{"key":"1253_CR33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","volume":"13","author":"SM Skevington","year":"2004","unstructured":"Skevington SM, Lotfy M, O\u2019Connell KA. The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL Group. Qual Life Res. 2004;13:299\u2013310.","journal-title":"Qual Life Res"},{"key":"1253_CR34","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/mds.21539","volume":"22","author":"BL Oudsten Den","year":"2007","unstructured":"Den Oudsten BL, Van Heck GL, De Vries J. The suitability of patient-based measures in the field of Parkinson\u2019s disease: a systematic review. Mov Disord. 2007;22:1390\u2013401.","journal-title":"Mov Disord."},{"key":"1253_CR35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.archger.2007.03.007","volume":"46","author":"MS Hirayama","year":"2008","unstructured":"Hirayama MS, Gobbi S, Gobbi LT, Stella F. Quality of life (QoL) in relation to disease severity in Brazilian Parkinson\u2019s patients as measured using the WHOQOL-BREF. Arch Gerontol Geriatr. 2008;46:147\u201360.","journal-title":"Arch Gerontol Geriatr."},{"key":"1253_CR36","first-page":"35","volume-title":"Measures in health psychology: a user\u2019s portfolio","author":"R Schwarzer","year":"1995","unstructured":"Schwarzer R, Jerusalem M. Generalized Self-Efficacy Scale. In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: a user\u2019s portfolio. Windsor: NFER-Nelson; 1995. p. 35\u20137."},{"key":"1253_CR37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/096020199389365","volume":"9","author":"JF Malec","year":"1999","unstructured":"Malec JF. Goal attainment scaling in rehabilitation. Neuropsychol Rehabil. 1999;9:253\u201375.","journal-title":"Neuropsychol Rehabil."},{"key":"1253_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ageing\/11.2.121","volume":"11","author":"JG Greene","year":"1982","unstructured":"Greene JG, Smith R, Gardiner M, Timbury GC. Measuring behavioural disturbance of elderly demented patients in the community and its effects on relatives: a factor analytic study. Age Ageing. 1982;11:121\u20136.","journal-title":"Age Ageing."},{"key":"1253_CR39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R, with the EuroQol Group. EuroQol: the current state of play. Health Policy. 1996;37:53\u201372.","journal-title":"Health Policy"},{"key":"1253_CR40","first-page":"179","volume-title":"Measuring mental health needs","author":"J Beecham","year":"1992","unstructured":"Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, Brewin C, Wing J, editors. Measuring mental health needs. London: Gaskill; 1992. p. 179\u201390."},{"key":"1253_CR41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427\u201342.","journal-title":"Neurology."},{"key":"1253_CR42","doi-asserted-by":"crossref","first-page":"a1655","DOI":"10.1136\/bmj.a1655","volume":"337","author":"P Craig","year":"2008","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.","journal-title":"BMJ."},{"key":"1253_CR43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1524-4733.2010.00788.x","volume":"13","author":"CH Ridyard","year":"2010","unstructured":"Ridyard CH, Hughes DA. Methods for the collection of resource use data within clinical trials: a systematic review of studies Funded by the UK Health Technology Assessment Program. Value Health. 2010;13:867\u201372.","journal-title":"Value Health."}],"updated-by":[{"DOI":"10.1186\/s13063-017-1849-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1253-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T14:47:49Z","timestamp":1600354069000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1253-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1186\/s13063-016-1253-0","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13063-017-1849-z","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]},"article-number":"152"}}